Waivio

AbbVie

stocks
0.00
American publicly traded biopharmaceutical company founded in 2013.
According to the Wall Street Journal as of January 2016 ibrutinib, a specialty drug, cost US$116,600 to $155,400 a year wholesale in the United States.

Experts

Followers